0001144204-19-030608.txt : 20190611
0001144204-19-030608.hdr.sgml : 20190611
20190611175108
ACCESSION NUMBER: 0001144204-19-030608
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190607
FILED AS OF DATE: 20190611
DATE AS OF CHANGE: 20190611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: van der Velden Peter
CENTRAL INDEX KEY: 0001778046
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37619
FILM NUMBER: 19891952
MAIL ADDRESS:
STREET 1: C/O EDESA BIOTECH INC.
STREET 2: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lumira Capital Investment Management Inc.
CENTRAL INDEX KEY: 0001702636
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37619
FILM NUMBER: 19891953
BUSINESS ADDRESS:
STREET 1: 141 ADELAIDE STREET WEST
STREET 2: SUITE 770
CITY: TORONTO
STATE: A6
ZIP: M5H 3L5
BUSINESS PHONE: 416-213-4223
MAIL ADDRESS:
STREET 1: 141 ADELAIDE STREET WEST
STREET 2: SUITE 770
CITY: TORONTO
STATE: A6
ZIP: M5H 3L5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edesa Biotech, Inc.
CENTRAL INDEX KEY: 0001540159
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 332 EAST SCOTT STREET
CITY: PORT HUENEME
STATE: CA
ZIP: 93041
BUSINESS PHONE: (805) 488-2800
MAIL ADDRESS:
STREET 1: 332 EAST SCOTT STREET
CITY: PORT HUENEME
STATE: CA
ZIP: 93041
FORMER COMPANY:
FORMER CONFORMED NAME: Stellar Biotechnologies, Inc.
DATE OF NAME CHANGE: 20120120
3
1
tv523427_3.xml
OWNERSHIP DOCUMENT
X0206
3
2019-06-07
1
0001540159
Edesa Biotech, Inc.
EDSA
0001778046
van der Velden Peter
C/O EDESA BIOTECH INC.
100 SPY COURT
MARKHAM
A6
L3R 5H6
ONTARIO, CANADA
1
0
1
0
0001702636
Lumira Capital Investment Management Inc.
141 ADELAIDE STREET WEST, SUITE 770
TORONTO
A6
M5H 3L5
ONTARIO, CANADA
0
0
1
0
This Form 3 is jointly filed by (i) Lumira Capital II, L.P., (ii) Lumira Capital II (International), L.P., (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc., (v) Lumira GP Holdings Co. and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P., the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of Lumira Capital II, L.P. and Lumira Capital II (International), L.P., and each of Lumira Capital II, L.P. and Lumira Capital II (International), L.P. is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc. Lumira GP Holdings Co. and Lumira Capital Investment Management Inc. Therefore, each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own shares of the Issuer held by Lumira Capital II, L.P. and Lumira Capital II (International), L.P.
/s/ Peter van der Velden
2019-06-11
LUMIRA CAPITAL INVESTMENT MANAGEMENT INC., /s/ Vasco Larcina, VP Finance
2019-06-11